![](https://d3ilqtpdwi981i.cloudfront.net/MDjakLilpBtq_WpxAFfz8kCDPJs=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/06/65/f1/0665f140-64e7-4083-ba3e-4d12d9701866/thumbnail_BPFile_object.jpg)
Article
A "Duty" to Continue Selling Medicines
American Journal of Law and Medicine
(2014)
Abstract
Recurring production/supply shortages of life-sustaining medicines occur. This article examines whether a patient who is prescribed such a medicine ought to have a legal remedy against the medicines supplier if the shortage is found to be negligently (or intentionally) caused. Finding that no such legal remedy exists presently, the article offers a statutory revision that might both safeguard patients against persistent supply interruptions and yet preserve the intellectual property holder's interest in its invention.
Disciplines
Publication Date
2014
Citation Information
William M Janssen. "A "Duty" to Continue Selling Medicines" American Journal of Law and Medicine Vol. 40 Iss. 4 (2014) p. 330 - 392 Available at: http://works.bepress.com/william_janssen/31/